A real-world study assessing the efficacy and safety of switching from basal bolus insulin therapy to once daily iGlarLixi in people with type 2 diabetes mellitus: soli de-escalation. - Giorgino F; Taybani Z; Cheng A; Tebaibia A; Anaforoglu İ; Lauand F; Servera S; Li X; Fonseca V (Diabetes research and clinical practice, 2025)